Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer-Reference-Cited by-同舟云学术

Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer

Published:2016-06-21 Issue:1 Volume:35 Page:
ISSN:1756-9966
Container-title:Journal of Experimental & Clinical Cancer Research
language:en
Short-container-title:J Exp Clin Cancer Res

Author:

Li Jianfa,Zhuang Chengle,Liu Yuchen,Chen Mingwei,Chen Yincong,Chen Zhicong,He Anbang,Lin Junhao,Zhan Yonghao,Liu Li,Xu Wen,Zhao Guoping,Guo Yinglu,Wu Hanwei,Cai Zhiming,Huang Weiren

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s13046-016-0372-5

Reference37 articles.

1. DeSantis CE, Lin CC, Mariotto AB, Siegel RL, Stein KD, et al. Cancer treatment and survivorship statistics. 2014. CA Cancer J Clin. 2014;64(4):252–71.

2. Nieder AM, Mackinnon JA, Huang Y, Fleming LE, Koniaris LG, et al. Florida bladder cancer trends 1981 to 2004: minimal progress in decreasing advanced disease. J Urol. 2008;179(2):491–5.

3. Chen J, Wang L, Tang Y, Gong G, Liu L, et al. Maspinm enhances cisplatin chemosensitivity in bladder cancer T24 and 5637 cells and correlates with prognosis of muscle- invasive bladder cancer. J Exp Clin Cancer Res. 2016;35:2.

4. Brausi MA. Primary prevention and early detection of bladder cancer: two main goals for urologists. Eur Urol. 2013;63(2):242–3.

5. Brausi M, Witjes JA, Lamm D, Persad R, Palou J, et al. A review of current guidelines and best practice recommendations for the management of nonmuscle invasive bladder cancer by the International Bladder Cancer Group. J Urol. 2011;186(6):2158–67.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Non-coding RNAs as therapeutic targets in cancer and its clinical application;Journal of Pharmaceutical Analysis;2024-07

2. Long non-coding RNAs in cancer: multifaceted roles and potential targets for immunotherapy;Molecular and Cellular Biochemistry;2024-02-28

3. Correction: Synthetic tetracycline-controllable shRNA targeting long non-coding RNA HOXD-AS1 inhibits the progression of bladder cancer;Journal of Experimental & Clinical Cancer Research;2023-11-28

4. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies;Biomedicine & Pharmacotherapy;2023-09

5. Role of non-coding RNAs in neuroblastoma;Cancer Gene Therapy;2023-05-22